Changgeng Qian - Net Worth and Insider Trading

Changgeng Qian Net Worth

The estimated net worth of Changgeng Qian is at least $297 dollars as of 2024-09-20. Changgeng Qian is the VP, Research & Preclinical Dev of Curis Inc and owns about 50 shares of Curis Inc (CRIS) stock worth over $297. Details can be seen in Changgeng Qian's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Changgeng Qian has not made any transactions after 2007-06-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Changgeng Qian

Changgeng Qian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Changgeng Qian owns 1 companies in total, including Curis Inc (CRIS) .

Click here to see the complete history of Changgeng Qian’s form 4 insider trades.

Insider Ownership Summary of Changgeng Qian

Ticker	Comapny	Transaction Date	Type of Owner
CRIS	Curis Inc	2007-06-06	VP & Research & Preclinical Dev

Changgeng Qian Latest Holdings Summary

Changgeng Qian currently owns a total of 1 stock. Changgeng Qian owns 50 shares of Curis Inc (CRIS) as of June 6, 2007, with a value of $297.

Latest Holdings of Changgeng Qian

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CRIS	Curis Inc	2007-06-06	50	5.93	297

Holding Weightings of Changgeng Qian

Changgeng Qian Form 4 Trading Tracker

According to the SEC Form 4 filings, Changgeng Qian has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the sale of 0 shares on June 6, 2007, which brought Changgeng Qian around $0.

Insider Trading History of Changgeng Qian

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Changgeng Qian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Changgeng Qian Ownership Network

Ownership Network List of Changgeng Qian

No Data

Ownership Network Relation of Changgeng Qian

Changgeng Qian Owned Company Details

What does Curis Inc do?

Who are the key executives at Curis Inc?

Changgeng Qian is the VP & Research & Preclinical Dev of Curis Inc. Other key executives at Curis Inc include CDO Jonathan B. Zung , CFO Diantha Duvall , and director & President & CEO James E Dentzer .

Curis Inc (CRIS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Curis Inc (CRIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Curis Inc (CRIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Curis Inc (CRIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Curis Inc Insider Transactions

No Available Data

Changgeng Qian Mailing Address

Above is the net worth, insider trading, and ownership report for Changgeng Qian. You might contact Changgeng Qian via mailing address: 45 Moulton Street, Cambridge Ma 02138.

Discussions on Changgeng Qian

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.